Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Conclus Forte
- Development stage
- Unknown
- Lead developer
- Lyf Healthcare
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Conclus Forte is a multivitamin and mineral supplement developed and marketed by Lyf Healthcare, an Indian pharmaceutical company. Formulated as an oral tablet, it contains essential nutrients such as methylcobalamin (Vitamin B12) and pyridoxine (Vitamin B6). It is indicated for general nutritional support and the prevention or treatment of vitamin and mineral deficiencies resulting from inadequate dietary intake, underlying health conditions, or increased nutritional requirements. As a nutraceutical, Conclus Forte provides broad metabolic support by supplying necessary cofactors for various physiological processes rather than targeting a specific molecular pathway.
- Brand names
- Conclus Forte
Beyond the preview
Go deeper on Conclus Forte.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Conclus Forte.